Comprehensive Management of Lower Urinary Tract Symptoms

Initial Evaluation and Assessment

The American Urological Association recommends obtaining a complete medical history focusing on genitourinary symptoms, duration, previous surgeries, general health issues, and sexual function in patients with lower urinary tract symptoms (LUTS) 3, 4
Validated symptom questionnaires such as International Prostate Symptom Score (IPSS) should be used to quantify symptom severity and bother in patients with LUTS 5, 2
A frequency-volume chart (voiding diary) for at least 3 days is recommended, particularly important with nocturia symptoms, to assess urinary patterns and fluid intake 6, 2
Bowel symptoms should be assessed separately, as liquid bowel incontinence suggests potential neurological issues or separate colorectal pathology 3

Urinalysis is recommended to rule out infection, hematuria, or other abnormalities in patients with LUTS 5, 2
Serum PSA testing is recommended if life expectancy is greater than 10 years and if prostate cancer diagnosis would change management 2
Post-void residual (PVR) measurement via bladder ultrasound is recommended to assess bladder emptying 6, 2
Uroflowmetry is recommended to assess maximum flow rate (Qmax) and voiding pattern in patients with LUTS 6, 2

Alpha-blocker therapy (e.g., tamsulosin 0.4 mg daily) is recommended as first-line treatment for voiding symptoms, including weak stream, with a rapid onset of action and low rate of adverse events 5, 2
5-alpha reductase inhibitors (5-ARIs) should be considered if prostate enlargement is greater than 30cc, with potential combination use with alpha-blockers for enlarged prostates 5, 8
Anticholinergics or beta-3 agonists may be added for storage symptoms (frequency) if alpha-blocker therapy is insufficient 5, 2

The combination of urinary symptoms with bowel incontinence raises concern for potential neurological etiology that requires careful evaluation, and multidisciplinary evaluation involving urology and gastroenterology may be necessary 3
Liquid bowel incontinence is not a typical feature of BPH/LUTS alone and warrants separate investigation 3

Reassessment is recommended 4-12 weeks after initiating treatment to evaluate response, including IPSS reassessment and potentially repeat PVR and uroflowmetry 5, 8
If inadequate response or intolerable side effects, consideration should be given to changing medical management or referral for surgical intervention 8